OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release
Shaobo Ruan, Yang Zhou, Xinguo Jiang, et al.
Advanced Science (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 150
Shaobo Ruan, Yang Zhou, Xinguo Jiang, et al.
Advanced Science (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 150
Showing 1-25 of 150 citing articles:
The blood–brain barrier: Structure, regulation and drug delivery
Di Wu, Qi Chen, Xiaojie Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 598
Di Wu, Qi Chen, Xiaojie Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 598
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 280
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 280
The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood–brain barrier and attenuates their targeting ability to brain tumor
Wei Xiao, Yazhen Wang, Huilin Zhang, et al.
Biomaterials (2021) Vol. 274, pp. 120888-120888
Closed Access | Times Cited: 129
Wei Xiao, Yazhen Wang, Huilin Zhang, et al.
Biomaterials (2021) Vol. 274, pp. 120888-120888
Closed Access | Times Cited: 129
Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy
Yanjie Liu, Wendie Wang, Dongya Zhang, et al.
Exploration (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 91
Yanjie Liu, Wendie Wang, Dongya Zhang, et al.
Exploration (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 91
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
Yan Zou, Yajing Sun, Yibin Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 83
Yan Zou, Yajing Sun, Yibin Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 83
Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies
Shuang Liang, Guangfu Liao, Wenzhen Zhu, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 75
Shuang Liang, Guangfu Liao, Wenzhen Zhu, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 75
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 75
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 75
Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease Therapy
Xiaotong Yang, Wenqin Yang, Xue Xia, et al.
Small (2022) Vol. 18, Iss. 30
Closed Access | Times Cited: 74
Xiaotong Yang, Wenqin Yang, Xue Xia, et al.
Small (2022) Vol. 18, Iss. 30
Closed Access | Times Cited: 74
The impact of protein corona on the biological behavior of targeting nanomedicines
Masoud Farshbaf, Hadi Valizadeh, Yunes Panahi, et al.
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121458-121458
Closed Access | Times Cited: 72
Masoud Farshbaf, Hadi Valizadeh, Yunes Panahi, et al.
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121458-121458
Closed Access | Times Cited: 72
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Qianqian Huang, Yongke Chen, Weiwei Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 519-534
Closed Access | Times Cited: 44
Qianqian Huang, Yongke Chen, Weiwei Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 519-534
Closed Access | Times Cited: 44
Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer’s Disease
Qianqian Huang, Chaoqing Jiang, Xue Xia, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 42
Qianqian Huang, Chaoqing Jiang, Xue Xia, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 42
Mannose-Integrated Nanoparticle Hitchhike Glucose Transporter 1 Recycling to Overcome Various Barriers of Oral Delivery for Alzheimer’s Disease Therapy
Ting Lei, Zixiao Yang, Chaoqing Jiang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3234-3250
Closed Access | Times Cited: 25
Ting Lei, Zixiao Yang, Chaoqing Jiang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3234-3250
Closed Access | Times Cited: 25
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 23
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 23
Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
Jun Yang, Yong Li, Shaoping Jiang, et al.
Exploration (2024)
Open Access | Times Cited: 20
Jun Yang, Yong Li, Shaoping Jiang, et al.
Exploration (2024)
Open Access | Times Cited: 20
Dual targeting of FR+CD44 overexpressing tumors by self-assembled nanoparticles quantitatively conjugating folic acid-hyaluronic acid to the GSH-sensitively modified podophyllotoxin
Chaozheng Zhang, Yao Chen, Yi Y. Zuo, et al.
Chemical Engineering Journal (2025), pp. 159276-159276
Closed Access | Times Cited: 3
Chaozheng Zhang, Yao Chen, Yi Y. Zuo, et al.
Chemical Engineering Journal (2025), pp. 159276-159276
Closed Access | Times Cited: 3
Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma
Zhi Li, Shaoping Jiang, Jie Wang, et al.
Science Advances (2025) Vol. 11, Iss. 3
Open Access | Times Cited: 2
Zhi Li, Shaoping Jiang, Jie Wang, et al.
Science Advances (2025) Vol. 11, Iss. 3
Open Access | Times Cited: 2
Advanced Nanoparticle Engineering for Precision Therapeutics of Brain Diseases
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 2
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 2
An update on actively targeted liposomes in advanced drug delivery to glioma
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, et al.
International Journal of Pharmaceutics (2021) Vol. 602, pp. 120645-120645
Closed Access | Times Cited: 89
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, et al.
International Journal of Pharmaceutics (2021) Vol. 602, pp. 120645-120645
Closed Access | Times Cited: 89
Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles
Xiaoqing Li, Vamsidhara Vemireddy, Qi Cai, et al.
Nano Letters (2021) Vol. 21, Iss. 22, pp. 9805-9815
Open Access | Times Cited: 76
Xiaoqing Li, Vamsidhara Vemireddy, Qi Cai, et al.
Nano Letters (2021) Vol. 21, Iss. 22, pp. 9805-9815
Open Access | Times Cited: 76
Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy
Di Wu, Fan Fei, Qi Zhang, et al.
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 64
Di Wu, Fan Fei, Qi Zhang, et al.
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 64
Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer
Wenfeng Jia, Rui Liu, Yushan Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 8, pp. 3354-3366
Open Access | Times Cited: 59
Wenfeng Jia, Rui Liu, Yushan Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 8, pp. 3354-3366
Open Access | Times Cited: 59
Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease
Kang Qian, Xiaoyan Bao, Yixian Li, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11455-11472
Closed Access | Times Cited: 57
Kang Qian, Xiaoyan Bao, Yixian Li, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11455-11472
Closed Access | Times Cited: 57
Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 51
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 51
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
Afsana Sheikh, Nabil A. Alhakamy, Shadab Md, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 50
Afsana Sheikh, Nabil A. Alhakamy, Shadab Md, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 50
